4.47

0.68% +0.03

Neurometrix Inc. (NURO)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$4.44

Aprire:

$4.5

Volume 24 ore:

12,699

Capitalizzazione di mercato:

$8.88M

Reddito:

$5.90M

Utile/perdita netta:

$-6.53M

Rapporto P/E:

-6.3055

EPS:

-0.7089

Flusso di cassa netto:

$-6.27M

1 W Prestazione:

+1.36%

1M Prestazione:

+12.88%

6M Prestazione:

+830.67%

1 anno Prestazione:

+221.58%

Intervallo 1D:

$4.30

$4.5001

Portata 52W:

$0.45

$4.70

Neurometrix Inc. Stock (NURO) Company Profile

Nome

Neurometrix Inc.

Settore

Healthcare (1210)

Industria

Medical Devices (156)

Telefono

781 890 9989

Indirizzo

4B Gill Street, Woburn

Dipendente

Cinguettio

Prossima data di guadagno

2024-05-01

Ultimi documenti SEC

NURO's Discussions on Twitter

Neurometrix Inc. Stock (NURO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2017-10-20	Reiterato	H.C. Wainwright	Buy
2016-06-28	Iniziato	Rodman & Renshaw	Buy
2015-09-11	Iniziato	Maxim Group	Buy
2012-02-27	Iniziato	Dawson James	Buy

Neurometrix Inc. Borsa (NURO) Ultime notizie

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

GlobeNewswire Inc.

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

GlobeNewswire Inc.

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call

GlobeNewswire Inc.

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024

GlobeNewswire Inc.

NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)

GlobeNewswire Inc.

NeuroMetrix Announces One-for-Eight Reverse Stock Split

GlobeNewswire Inc.

Neurometrix Inc. Azioni (NURO) Dati Finanziari